CBC Group, an Asia healthcare-dedicated asset management firm, has announced the closing of its R-Bridge Healthcare Fund II (RBF II) with $500m in total capital commitments.
RBF II represents one of the largest private credit funds focused on healthcare raised to date for an Asia based firm. RBF II invests on a global basis while supporting healthcare innovation and growth of healthcare innovators, said CBC.
The fund attracted a variety of global institutional investors from sovereign wealth funds, corporate pensions, financial institutions and family offices.
Its approach provides royalty and revenue-backed financing structures to healthcare companies with approved and commercial-stage therapeutics and medical technologies across Europe, Asia and globally. The non-dilutive financing is intended to support commercial growth while offering investors risk-adjusted returns with downside protection.
R-Bridge was founded in 2020 to provide alternative, non-dilutive financing for healthcare companies backed by royalties, revenue interests and other cash flow generated by sales of healthcare products and services in Asia as well as globally, with the intent to generate attractive and non-correlated returns for investors.
R-Bridge is an affiliate of CBC Group, a Singapore-headquartered healthcare-dedicated asset management firm with about $11bn of asset under management.